Drug Shortage Report for CLADRIBINE INJECTION

Last updated on 2024-02-27 History
Report ID 217270
Drug Identification Number 02494574
Brand name CLADRIBINE INJECTION
Common or Proper name CLADRIBINE INJECTION
Company Name GENERIC MEDICAL PARTNERS INC
Market Status MARKETED
Active Ingredient(s) CLADRIBINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1mg/ml 10ml Vial
ATC code L01BB
ATC description ANTIMETABOLITES
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-01-25
Actual start date 2024-01-25
Estimated end date 2024-02-15
Actual end date 2024-02-26
Shortage status Resolved
Updated date 2024-02-27
Company comments Cladribine Injection 1mg/ml 10 ml vial UPC 870573001434 is now available. It is not on allocation. Normal demand levels can be supplied.
Health Canada comments
Tier 3 Status No
Contact Address 1500 DON MILLS ROAD, SUITE 711
TORONTO, ONTARIO
CANADA M3B 3K4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-02-27 English Compare
v6 2024-02-26 English Compare
v5 2024-02-26 French Compare
v4 2024-02-26 English Compare
v3 2024-01-26 English Compare
v2 2024-01-25 French Compare
v1 2024-01-25 English Compare

Showing 1 to 7 of 7